SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-011193
Filing Date
2024-08-07
Accepted
2024-08-07 06:32:25
Documents
15
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tech-20240807x8k.htm   iXBRL 8-K 36030
2 EX-99.1 tech-20240807xex99d1.htm EX-99.1 617513
3 EX-99.2 tech-20240807xex99d2.htm EX-99.2 21197
  Complete submission text file 0001558370-24-011193.txt   835246

Data Files

Seq Description Document Type Size
4 EX-101.SCH tech-20240807.xsd EX-101.SCH 3241
5 EX-101.LAB tech-20240807_lab.xml EX-101.LAB 15263
6 EX-101.PRE tech-20240807_pre.xml EX-101.PRE 10902
17 EXTRACTED XBRL INSTANCE DOCUMENT tech-20240807x8k_htm.xml XML 4603
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 241181316
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)